This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2016 Jan;18 Suppl 1(Suppl 1):i1-i50.

doi: 10.1093/neuonc/nov297.

American Brain Tumor Association Adolescent and Young Adult Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012

Affiliations

Affiliations

¹ Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH USA Central Brain Tumor Registry of the United States, Hinsdale, IL USA.
² Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH USA Department of Pediatric Hematology-Oncology, Rainbow Babies and Children s Hospital, Cleveland, OH USA.
³ Division of Hematology, Oncology and BMT, Nationwide Children's Hospital and The Ohio State University, Columbus, OH USA.
⁴ School of Public Health, University of Memphis, Memphis, TN USA.
⁵ Keck School of Medicine, University of Southern California, Los Angeles, CA USA.
⁶ Department of Pediatric Hematology and Oncology, Cleveland Clinic Children's Hospital, Cleveland, OH USA.
⁷ Solon High School, Solon, OH USA.
⁸ Central Brain Tumor Registry of the United States, Hinsdale, IL USA.

PMID: 26705298
PMCID: PMC4690545
DOI: 10.1093/neuonc/nov297

American Brain Tumor Association Adolescent and Young Adult Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012

Quinn T Ostrom et al. Neuro Oncol. 2016 Jan.

. 2016 Jan;18 Suppl 1(Suppl 1):i1-i50.

doi: 10.1093/neuonc/nov297.

Affiliations

¹ Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH USA Central Brain Tumor Registry of the United States, Hinsdale, IL USA.
² Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH USA Department of Pediatric Hematology-Oncology, Rainbow Babies and Children s Hospital, Cleveland, OH USA.
³ Division of Hematology, Oncology and BMT, Nationwide Children's Hospital and The Ohio State University, Columbus, OH USA.
⁴ School of Public Health, University of Memphis, Memphis, TN USA.
⁵ Keck School of Medicine, University of Southern California, Los Angeles, CA USA.
⁶ Department of Pediatric Hematology and Oncology, Cleveland Clinic Children's Hospital, Cleveland, OH USA.
⁷ Solon High School, Solon, OH USA.
⁸ Central Brain Tumor Registry of the United States, Hinsdale, IL USA.

PMID: 26705298
PMCID: PMC4690545
DOI: 10.1093/neuonc/nov297

No abstract available

PubMed Disclaimer

Figures

Fig. 1. — Fig. 1.
Average Annual Age-Adjusted Incidence Rates for the Five Most Common Cancers in Persons Age A) 15-39 Years, B) 15-19 Years, C) 20-24 Years, D) 25-29 Years, E) 30-34 Years, and F) 35-39 Years, (CBTRUS 2008-2012 and USCS 2008-2012).

Fig. 2. — Fig. 2.
Average Annual Age-Adjusted and Crude Mortality Rates for the Five Most Common Causes of Death Due to Cancer in Persons Age A) 15-39 Years, B) 15-19 Years, C) 20-24 Years, D) 25-29 Years, E) 30-34 Years, and F) 35-39 Years, (NVSS 2008-2012).

Fig. 3. — Fig. 3.
Average Annual Age-Adjusted Incidence Rates and Annual Average Cases^a of Primary Brain and CNS Tumors by Age Groups (15-39 Years), (CBTRUS 2008-2012).

Fig. 4a. — Fig. 4a.
Average Annual Age-Adjusted Incidence Rates of All Primary Brain and CNS Tumors by Region of the United States (Age 15-39 Years), (CBTRUS 2008-2012).

Fig. 4b. — Fig. 4b.
Average Annual Age-Adjusted Incidence Rates of All Malignant Brain and CNS Tumors by Region of the United States (Age 15-39 Years), (CBTRUS 2008-2012).

Fig. 4c. — Fig. 4c.
Average Annual Age-Adjusted Incidence Rates of All Non-Malignant Brain and CNS Tumors by Region of the United States (Age 15-39 Years), (CBTRUS 2008-2012).

Fig. 5. — Fig. 5.
Distribution^a of All Primary Brain and CNS Tumors by Site, Age 15-39 Years (Five-Year Total = 53,083), (CBTRUS 2008-2012).

Fig. 6. — Fig. 6.
Distribution^a of All Primary Brain and CNS Tumors by Site and Age Groups A) 15-19 Years (Five-Year Total = 6,747), B) 20-24 Years (Five-Year Total = 7,765), C) 25-29 Years (Five-Year Total = 10,385), D) 30-34 Years (Five-Year Total = 12,626), and E) 35-39 Years (Five-Year Total = 15,560), (CBTRUS 2008-2012).

Fig. 7. — Fig. 7.
Distribution^a of Primary Malignant Brain and CNS Tumors by Site, Age 15-39 Years (Five-Year Total = 16,742), (CBTRUS 2008-2012).

Fig. 8. — Fig. 8.
Distribution^a of Primary Malignant Brain and CNS Tumors by Site and Age Groups A) 15-19 Years (Five-Year Total = 2,747), B) 20-24 Years (Five-Year Total = 2,728), C) 25-29 Years (Five-Year Total = 3,421), D) 30-34 Years (Five-Year Total = 3,721), and E) 35-39 Years (Five-Year Total = 4,125), (CBTRUS 2008-2012).

Fig. 9. — Fig. 9.
Distribution^a of Non-Malignant Primary Brain and CNS Tumors by Site, Age 15-39 Years (Five-Year Total = 36,341), (CBTRUS 2008-2012).

Fig. 10. — Fig. 10.
Distribution^a of Non-Malignant Primary Brain and CNS Tumors by Site by Age Groups A) 15-19 Years (Five-Year Total = 4,000), B) 20-24 Years (Five-Year Total = 5,037), C) 25-29 Years (Five-Year Total = 6,964), D) 30-34 Years (Five-Year Total = 8,905), and E) 35-39 Years (Five-Year Total = 11,435), (CBTRUS 2008-2012).

Fig. 11. — Fig. 11.
Distribution^a of All Primary Brain and CNS Tumors by Histology, Age 15-39 Years (Five-Year Total = 53,083), (CBTRUS 2008-2012).

Fig. 12. — Fig. 12.
Distribution^a of All Primary Brain and CNS Tumors by Histology by Age Groups A) 15-19 Years (Five-Year Total = 6,747), B) 20-24 Years (Five-Year Total = 7,765), C) 25-29 Years (Five-Year Total = 10,385), D) 30-34 Years (Five-Year Total = 12,626), and E) 35-39 Years (Five-Year Total = 15,560), (CBTRUS 2008-2012).

Fig. 13. — Fig. 13.
Distribution^a of Primary Malignant Brain and CNS Tumors by Histology, Age 15-39 Years (Five-Year Total = 16,742), (CBTRUS 2008-2012).

Fig. 14. — Fig. 14.
Distribution^a of Primary Malignant Brain and CNS Tumors by Histology by Age Groups A) 15-19 Years (Five-Year Total = 2,747), B) 20-24 Years (Five-Year Total = 2,728), C) 25-29 Years (Five-Year Total = 3,421), D) 30-34 Years (Five-Year Total = 3,721), and E) 35-39 Years (Five-Year Total = 4,125), (CBTRUS 2008-2012).

Fig. 15. — Fig. 15.
Distribution^a of Non-Malignant Primary Brain and CNS Tumors by Histology, Age 15-39 Years (Five-Year Total = 36,341), (CBTRUS 2008-2012).

Fig. 16. — Fig. 16.
Distribution^a of Non-Malignant Primary Brain and CNS Tumors by Histology and Age Groups A) 15-19 Years (Five-Year Total = 4,000), B) 20-24 Years (Five-Year Total = 5,037), C) 25-29 Years (Five-Year Total = 6,964), D) 30-34 Years (Five-Year Total = 8,905), and E) 35-39 Years (Five-Year Total = 11,435), (CBTRUS 2008-2012).

Fig. 17. — Fig. 17.
Distribution^a of Gliomas by Site, Age 15-39 Years (Five-Year Total = 15,002), (CBTRUS 2008-2012).

Fig. 18. — Fig. 18.
Distribution^a of Gliomas by Site and Age Groups A) 15-19 Years (Five-Year Total = 2,327), B) 20-24 Years (Five-Year Total = 2,381), C) 25-29 Years (Five-Year Total = 3,112), D) 30-34 Years (Five-Year Total = 3,454), and E) 35-39 Years (Five-Year Total = 3,728), (CBTRUS 2008-2012).

Fig. 19. — Fig. 19.
Distribution^a of Gliomas by Histology, Age 15-39 Years (Five-Year Total = 15,002), (CBTRUS 2008-2012).

Fig. 20. — Fig. 20.
Distribution^a of Gliomas by Histology by Age Groups, A) 15-19 Years (Five-Year Total = 2,327), B) 20-24 Years (Five-Year Total = 2,381), C) 25-29 Years (Five-Year Total = 3,112), D) 30-34 Years (Five-Year Total = 3,454), and E) 35-39 Years (Five-Year Total = 3,728), (CBTRUS 2008-2012).

Fig. 21. — Fig. 21.
Incidence Rate Ratios by Gender (Males:Females) in Adolescents and Young Adults Age 15-39 Years for Selected CBTRUS Histology Groupings and Histologies, (CBTRUS 2008-2012).

Fig. 22. — Fig. 22.
Incidence Rate Ratios by Race (Whites:Blacks) in Adolescents and Young Adults Age 15-39 Years for Selected CBTRUS Histology Groupings and Histologies, (CBTRUS 2008-2012).

Fig. 23. — Fig. 23.
Average Annual Age-Adjusted Mortality Rates of All Malignant Brain and CNS Tumors by Region of the United States (Age 15-39 Years), (NVSS 2008-2012).

Fig. 24. — Fig. 24.
Relative Survival For 1, 2, 3, 4, 5 and 10 Years after Diagnosis with a Glioma in Persons Age 15-39 Years by A) Age Groups, B) Sex, C) Race/Ethnicity, and D) Insurance Status (data available only from 2007-2012), (SEER 1995-2012).

Fig. 25. — Fig. 25.
Five-Year Conditional Survival by Age Groups and Histology Groupings (Age 15-39 Years), (SEER 1995-2012).

See this image and copyright information in PMC

References

1. Bleyer A, Barr R, Hayes-Lattin B, et al. The distinctive biology of cancer in adolescents and young adults. Nat. Rev. Cancer. Apr 2008;8(4):288–298. - PubMed
1. Tricoli JV, Seibel NL, Blair DG, et al. Unique characteristics of adolescent and young adult acute lymphoblastic leukemia, breast cancer, and colon cancer. J Natl Cancer Inst. Apr 20 2011;103(8):628–635. - PMC - PubMed
1. Ostrom QT, Gittleman H, Fulop J, et al. CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008–2012. Neuro Oncol. Oct 2015;17(Suppl 4):iv1–iv62. - PMC - PubMed
1. Ostrom QT, de Blank PM, Kruchko C, et al. Alex's Lemonade Stand Foundation Infant and Childhood Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007–2011. Neuro Oncol. Jan 2015;16(Suppl 10):x1–x36. - PMC - PubMed
1. Lewis DR, Seibel NL, Smith AW, Stedman MR. Adolescent and young adult cancer survival. J. Natl. Cancer Inst. Monogr. Nov 2014;2014(49):228–235. - PMC - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

K12 CA076917/CA/NCI NIH HHS/United States

LinkOut - more resources

Full Text Sources
Other Literature Sources
- The Lens - Patent Citations Database
- scite Smart Citations
Medical
- MedlinePlus Health Information